Tag Archives: AI drug discovery

September 26, 2019
Potential diagnostic tool, treatment for Parkinson’s disease
In The News

Science Daily reports on a recent publication by researchers at Stanford, Mayo Clinic, and Atomwise.

Read Article
September 11, 2019
Atomwise Announces Largest China-US Collaboration for AI Drug Discovery
Press Release

Atomwise could receive up to US$1.5 billion to develop first in-class and best in-class small molecules through partnership with China’s leading biopharmaceutical company, Hansoh Pharma.

Read Article
September 11, 2019
Atomwise Enters Three Joint Ventures to Use AI Platform for Drug Development
In The News

Mark Terry of BioSpace reports on Atomwise’s three new joint ventures.

Read Article
September 11, 2019
Atomwise and Atropos Launch Joint Venture to Discover Senescence Modulating Small Molecules for Cancer Patients
Press Release

Atomwise and Atropos Therapeutics form a joint venture to discover and develop anticancer agents using senescence assay and AI technologies.

Read Article
September 10, 2019
Atomwise inks two joint ventures in AI-based cancer drug development
In The News

Connor Hale at FierceBiotech writes about Atomwise’s new joint ventures with SEngine Precision Medicine and OncoStatyx.

Read Article
July 23, 2019
What’s Your Moonshot? Abraham Heifets of Atomwise Is Using AI to Speed up the Development of Medications Targeted at Specific Cancer Cells
In The News

Noah Miller of Newsweek interviews Abraham Heifets, Atomwise CEO, about his Moonshot.

Read Article